Addus HomeCare (ADUS) EVP sells shares and receives stock award

Rhea-AI Filing Summary

Addus HomeCare Corp EVP and Chief Development Officer Cliff Donald Blessing reported mixed share activity. He sold 371 shares of common stock in an open-market transaction at $114.91 per share under a pre-set 10b5-1 plan to cover tax obligations. He also received a grant of 2,858 restricted shares that vest in equal installments on February 20, 2027, February 20, 2028, and February 20, 2029. Following these transactions, he directly holds 12,888 shares.

Insider Trade Summary

Net Seller: 371 shares ($42,632)

Net Sell 2 txns

Insider BLESSING CLIFF DONALD

Role EVP, Chief Development Officer

Sold 371 shs ($43K)

Type	Security	Shares	Price	Value
Sale	Common Stock	371	$114.91	$43K
Grant/Award	Common Stock	2,858	$0.00	--

Holdings After Transaction: Common Stock — 12,888 shares (Direct)

Footnotes (1)

1. The shares vest in equal installments on each of February 20, 2027, February 20, 2028, and February 20, 2029, subject to customary provisions for continued service and acceleration on a change in control. This transaction reflects the sale of shares, made pursuant to a previously established 10b5-1 plan, for the purpose of satisfying tax obligations due upon the vesting of restricted stock awards granted by the Issuer. Adoption date of referenced 10b5-1(c) plan is: 03/14/2025

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BLESSING CLIFF DONALD

(Last) (First) (Middle)

6303 COWBOYS WAY

SUITE 600

(Street)

FRISCO TX 75034

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Addus HomeCare Corp [ ADUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Development Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/20/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/20/2026		A		2,858(1)	A	$0	13,259	D
Common Stock	02/23/2026		S(2)(3)		371	D	$114.91	12,888	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares vest in equal installments on each of February 20, 2027, February 20, 2028, and February 20, 2029, subject to customary provisions for continued service and acceleration on a change in control.

2. This transaction reflects the sale of shares, made pursuant to a previously established 10b5-1 plan, for the purpose of satisfying tax obligations due upon the vesting of restricted stock awards granted by the Issuer.

3. Adoption date of referenced 10b5-1(c) plan is: 03/14/2025

	/s/ Brian Poff, Attorney-in-Fact for Cliff Donald Blessing	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Addus HomeCare (ADUS) EVP Cliff Donald Blessing report?

Cliff Donald Blessing reported a small open-market sale and a stock grant. He sold 371 Addus HomeCare common shares and received 2,858 restricted shares, reflecting both a tax-related disposition and an equity-based compensation award in a single Form 4 filing.

How many Addus HomeCare (ADUS) shares did the EVP sell and at what price?

He sold 371 shares of Addus HomeCare common stock at $114.91 per share. The filing states this was an open-market transaction executed under a Rule 10b5-1 trading plan, primarily to satisfy tax obligations arising from previously vested restricted stock awards.

What equity award did the Addus HomeCare (ADUS) EVP receive in this Form 4?

He received a grant of 2,858 shares of restricted common stock. According to the disclosure, these shares vest in three equal installments on February 20 in 2027, 2028, and 2029, contingent on continued service and subject to change-in-control acceleration provisions.

How do the new transactions affect the EVP’s Addus HomeCare (ADUS) holdings?

After the reported sale and award, he directly owns 12,888 Addus HomeCare shares. The Form 4 shows this post-transaction balance for his common stock, reflecting both the tax-motivated sale and the addition of unvested restricted shares granted as part of his compensation.

Was the Addus HomeCare (ADUS) EVP’s stock sale discretionary or pre-planned?

The sale was executed under a previously established Rule 10b5-1 trading plan. Footnotes explain the shares were sold to satisfy tax obligations triggered by vesting of restricted stock awards, indicating a pre-planned, tax-driven transaction rather than an opportunistic discretionary sale.

When will the EVP’s new Addus HomeCare (ADUS) restricted shares vest?

The 2,858 restricted shares vest in three equal annual installments. Vesting dates are February 20, 2027, February 20, 2028, and February 20, 2029, assuming continued service, with customary provisions for acceleration if there is a qualifying change in control of the company.